WebJul 24, 2013 · TROUBLED biotechnology company Phosphagenics has taken steps to recoup nearly 5.7 million in misappropriated funds, confirming that it had lodged caveats over several properties owned by its ... WebOct 26, 2024 · MELBOURNE – Promising clinical trial results for Phosphagenics Ltd.’s transdermal analgesic patches have eased the pain of a year bruised by surprise allegations of fraud against the Melbourne biotech’s former CEO Esra Ogru. Phosphagenics founder and major shareholder Harry Rosen flew back from New York to take the reins mid-year, but he …
Former chief executive pleads guilty to $6 million fraud …
WebMay 21, 2014 · Phosphagenics Limited is commercialising drug delivery applications based on its novel transdermal (drugs administered via skin) TPM ® -- Targeted Penetration Matrix technology. TPM ® is a... WebNov 12, 2024 · Today’s verdict. “As shareholders will recognise, this arbitration loss has a serious impact on the company and the board will need to carefully consider the alternative courses of action available to it,” Phosphagenics stated. Final costs are yet to be awarded. Phosphagenics noted it had spent about $5.6 million on legal and arbitration ... portable desks for small spaces
Phosphagenics
WebTHE former chief executive of Phosphagenics, Esra Ogru, faces up to 10 years in jail after admitting to defrauding the company of more than $6.1 million. WebMay 24, 2024 · PHOSPHAGENICS LIMITED. Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its drug delivery system Tocopherol Phosphate Mixture (TPM). The Company's products pipeline includes Weaner Pig Starter TPM premix, Poultry TPM, … WebAug 22, 2014 · The fraud came to light following an audit of Phosphagenics' books last year and Dr Ogru has already agreed to repay some of the stolen funds. Phosphagenics is developing an opiod skin patch to ... irrigation of peritoneal cavity